Pump blockers and ulcer disease.
暂无分享,去创建一个
[1] J. Jansen,et al. Omeprazole in Zollinger-Ellison syndrome. Effects of a single dose and of long-term treatment in patients resistant to histamine H2-receptor antagonists. , 1984, The New England journal of medicine.
[2] G. Sachs,et al. Inhibition of gastric (H+ + K+)-ATPase by the substituted benzimidazole, picoprazole. , 1983, Biochimica et biophysica acta.
[3] B. Hirschowitz,et al. Inhibition of Basal Acid, Chloride, and Pepsin Secretion in Duodenal Ulcer by Graded Doses of Ranitidine and Atropine with Studies of Pharmacokinetics of Ranitidine , 1982 .
[4] G. Sachs,et al. Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+) ATPase , 1981, Nature.
[5] N. Birdsall,et al. Pirenzepine distinguishes between different subclasses of muscarinic receptors , 1980, Nature.
[6] J. G. Forte,et al. K + -stimulated ATPase in purified microsomes of bullfrog oxyntic cells. , 1973, Biochimica et biophysica acta.
[7] J. Black,et al. Definition and Antagonism of Histamine H2-receptors , 1972, Nature.